Experiments showed that after injecting bone marrow mesenchymal stem cells (BM-MSCs) into the AD model with increased NF-κB expression in the hippocampus, the inflammation of mice was reduced, and the level of miRNA-146a in the hippocampus was increased. The gene discussed is NFKB1; the disease is Alzheimer disease.